$CI · The Cigna Group

This SEC Form 4 filing reports equity compensation awarded to Brian C. Evanko, the President and Chief Executive Officer of The Cigna Group. On September 1, 2026, Evanko received 3,113 restricted shares of Cigna common stock at no cost. These restricted shares vest in three equal annual installments beginning September 1, 2027. He also received an employee stock option to buy 6,716 shares of common stock at an exercise price of $281.1325 per share. That option vests in three equal annual installments beginning September 1, 2027, and expires on September 1, 2037.

After these transactions, Evanko directly held 41,030 shares of common stock. He also indirectly held 25,614 shares through a GRAT and 919.5791 shares through the company’s 401(k) plan. The filing reports only the acquisition of equity awards and does not disclose any sale or disposition of securities.